China Shineway Pharmaceutical Group Limited (2877.HK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for China Shineway Pharmaceutical Group Limited, with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | 6.13x |
| P/B Ratio | 0.72x |
| P/S Ratio | 1.86x |
| Profitability | |
| Gross Margin | 72.3% |
| Operating Margin | 21.8% |
| Net Margin | 30.3% |
| EBITDA Margin | 23.6% |
| Liquidity | |
| Current Ratio | 3.71x |
| Quick Ratio | 3.43x |
| Leverage | |
| Debt/Equity | 0.04x |
YoY = year-over-year change. Source: FMP..